Inhibition of TGF-beta and VEGF expression in human endothelium cell lines with antisense-oligonucleotides: potential tools for gene therapy of chronic renal transplant rejection.
Hallscheidt
P
P
Department of Radiology, University of Heidelberg, Heidelberg, Germany.
Wallich
R
R
Kauffmann
G W
GW
Pomer
S
S
D002460:Cell Line; D016228:Endothelial Growth Factors / Q000235:genetics*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D005786:Gene Expression Regulation / Q000187:drug effects*; D015316:Genetic Therapy; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000235:genetics; D007375:Interleukin-1 / Q000494:pharmacology; D015850:Interleukin-6 / Q000494:pharmacology; D016030:Kidney Transplantation / Q000276:immunology; D008222:Lymphokines / Q000235:genetics*; D020319:Oligodeoxyribonucleotides, Antisense / Q000494:pharmacology*; D010982:Platelet-Derived Growth Factor / Q000235:genetics; D014162:Transfection; D016212:Transforming Growth Factor beta / Q000235:genetics*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D007375:Interleukin-1; D015850:Interleukin-6; D008222:Lymphokines; D020319:Oligodeoxyribonucleotides, Antisense; D010982:Platelet-Derived Growth Factor; D016212:Transforming Growth Factor beta; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D018799:Intercellular Adhesion Molecule-1